Bioadaptives, Inc. (BDPT) Revenue (2016 - 2026)
Bioadaptives (BDPT) posted Revenue of $5514.0 for Q1 2026, down 47.12% sequentially from $10427.0 in Q4 2025.
Bioadaptives, Inc. (BDPT) Revenue (2016 - 2026) Analysis & Trends
Bioadaptives has reported Revenue for 9 years, with the latest figure at $5514.0 in Q1 2026.
- Quarterly Revenue changed N/A year-over-year to $5514.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23792.0 (up 3424.74% YoY) and the FY2025 annual result came in at $18278.0, up 44.27% from the prior year.
- Revenue retreated to $5514.0 in Q1 2026 per BDPT's latest filing, from $10427.0 in the prior quarter.
- Over five years, Revenue peaked at $15649.0 in Q3 2023 and troughed at $675.0 in Q2 2024.
- A 5-year average of $5871.6 and a median of $4477.0 in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue plunged 71.14% in 2024, then surged 376.89% in 2025.
- Over 5 years, Revenue stood at $3984.0 in 2022, then surged by 80.75% to $7201.0 in 2023, then sank by 90.63% to $675.0 in 2024, then soared by 1444.74% to $10427.0 in 2025, then sank by 47.12% to $5514.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $5514.0, $10427.0, and $4632.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,514.00 |
| Dec 31, 2025 | 10,427.00 |
| Sep 30, 2025 | 4,632.00 |
| Jun 30, 2025 | 3,219.00 |
| Jun 30, 2024 | 675.00 |
| Mar 31, 2024 | 11,994.00 |
| Dec 31, 2023 | 7,201.00 |
| Sep 30, 2023 | 15,649.00 |
| Jun 30, 2023 | 2,339.00 |
| Mar 31, 2023 | 3,376.00 |
| Dec 31, 2022 | 3,984.00 |
| Sep 30, 2022 | 3,337.00 |
| Jun 30, 2022 | 4,322.00 |
| Mar 31, 2022 | 5,533.00 |
| Dec 31, 2021 | 3,851.00 |
| Sep 30, 2021 | 5,342.00 |
| Jun 30, 2021 | 6,065.00 |
| Mar 31, 2021 | 4,518.00 |
| Dec 31, 2020 | 3,731.00 |
| Sep 30, 2020 | 4,439.00 |